{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:02Z","timestamp":1786120382819,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/mph.0b013e3182331bc7","type":"journal-article","created":{"date-parts":[[2011,10,28]],"date-time":"2011-10-28T15:43:40Z","timestamp":1319816620000},"page":"e333-e341","source":"Crossref","is-referenced-by-count":42,"title":["Oral Voriconazole Versus Intravenous Low Dose Amphotericin B for Primary Antifungal Prophylaxis in Pediatric Acute Leukemia Induction"],"prefix":"10.1097","volume":"33","author":[{"given":"Sushil","family":"Mandhaniya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetanya","family":"Swaroop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Thulkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivas","family":"Vishnubhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil K.","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculata","family":"Xess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.2000.02014.x","article-title":"Towards a targeted, risk-based, antifungal strategy in neutropenic patients.","volume":"110","author":"Prentice","year":"2000","journal-title":"Br J Haematol"},{"key":"R2-18-20210227","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/21.2.361","article-title":"Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen.","volume":"21","author":"Bow","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R3-18-20210227","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/164.4.731","article-title":"Clinical features and analysis of risk factors for invasive candidiasis infection after marrow transplantation.","volume":"164","author":"Goodrich","year":"1991","journal-title":"J Infect Dis"},{"key":"R4-18-20210227","first-page":"1","article-title":"Invasive fungal infection in patients receiving intensive cytotoxic therapy for cancer.","volume":"101","author":"Bow","year":"1998","journal-title":"Br J Haematol"},{"key":"R5-18-20210227","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/clinids\/13.3.493","article-title":"Problems in the diagnosis of invasive fungal diseases.","volume":"13","author":"Rinaldi","year":"1991","journal-title":"Rev Infect Dis"},{"key":"R6-18-20210227","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bmt.1702232","article-title":"Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients.","volume":"25","author":"Jantunen","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R7-18-20210227","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(97)89455-7","article-title":"The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis.","volume":"100","author":"Horvath","year":"1996","journal-title":"Am J Med"},{"key":"R8-18-20210227","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/sj.bmt.1702045","article-title":"Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis.","volume":"24","author":"Reichenberger","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"R9-18-20210227","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.1990.8.2.280","article-title":"Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.","volume":"8","author":"Wiley","year":"1990","journal-title":"J Clin Oncol"},{"key":"R10-18-20210227","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.mph.0000155861.38641.ca","article-title":"Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.","volume":"27","author":"Rosen","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"R11-18-20210227","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/pbc.20717","article-title":"Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.","volume":"48","author":"Hovi","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R12-18-20210227","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<344::AID-MPO6>3.0.CO;2-6","article-title":"Fungal colonization and infection in children with acute leukemia and lymphoma during induction therapy.","volume":"32","author":"Gozdasoglu","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"R13-18-20210227","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/08880010500457327","article-title":"Invasive fungal infections in children with haematological malignancies. A 5-year study.","volume":"23","author":"Athanassiadou","year":"2006","journal-title":"Pediatr Hematol Oncol"},{"key":"R14-18-20210227","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01974614","article-title":"A multicentre study of fluconazole versus oral polyenes in prevention of fungal infection in children with haematological or oncological malignancies: multicentre study Group.","volume":"13","author":"Ninane","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R15-18-20210227","first-page":"974","article-title":"Prevention of fungal infections in the immunocompromised host.","volume":"4","author":"Mahfouz","year":"2003","journal-title":"Curr Opin Investig Drugs"},{"key":"R16-18-20210227","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after bone marrow transplantation: a prospective, randomized, double-blind study.","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"R17-18-20210227","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"R18-18-20210227","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/1097-0142(19940415)73:8<2099::AID-CNCR2820730814>3.0.CO;2-N","article-title":"Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B.","volume":"73","author":"Bodey","year":"1994","journal-title":"Cancer"},{"key":"R19-18-20210227","doi-asserted-by":"crossref","first-page":"495","DOI":"10.7326\/0003-4819-118-7-199304010-00003","article-title":"Fluconazole prophylaxis of fungal infections in patients with acute leukemia: Result of a randomized placebo-controlled, double-blind, multicenter trial.","volume":"118","author":"Winston","year":"1993","journal-title":"Ann Intern Med"},{"key":"R20-18-20210227","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/02681219380000311","article-title":"Fluconazole in patients at risk from invasive aspergillosis.","volume":"31","author":"Kappe","year":"1993","journal-title":"J Med Vet Mycol"},{"key":"R21-18-20210227","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida Krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"R22-18-20210227","first-page":"74","article-title":"Fluconazole and itraconazole: current status and prospects for antifungal therapy.","volume":"13","author":"Sugar","year":"1993","journal-title":"Curr Clin Top Infect Dis"},{"issue":"Suppl 1","key":"R23-18-20210227","first-page":"3","article-title":"In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.","volume":"38","author":"Van Custem","year":"1992","journal-title":"Chemotherapy"},{"key":"R24-18-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/28.4.555","article-title":"Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia.","volume":"28","author":"Bradford","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"R25-18-20210227","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/0959-8049(92)90127-N","article-title":"Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment.","volume":"28A","author":"Persat","year":"1992","journal-title":"European Journal of cancer"},{"key":"R26-18-20210227","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bmt.1702233","article-title":"Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.","volume":"25","author":"Wollf","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R27-18-20210227","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"R28-18-20210227","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000238990","article-title":"Fluconazole in children: first experience with prophylaxis in pediatric patients with cancer.","volume":"39","author":"Cap","year":"1993","journal-title":"Chemotherapy"},{"key":"R29-18-20210227","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/pbc.21868","article-title":"Invasive fungal infections in pediatric leukemia patients receiving fluconazole prophylaxis.","volume":"52","author":"Kaya","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R30-18-20210227","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1399-3046.2006.00643.x","article-title":"Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.","volume":"11","author":"Grigull","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R31-18-20210227","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00520-006-0125-7","article-title":"Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants.","volume":"15","author":"Simon","year":"2007","journal-title":"Support Care Cancer"},{"key":"R32-18-20210227","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/pbc.22140","article-title":"Antifungal prophylaxis with micafungin in patients treated for childhood cancer.","volume":"53","author":"Kusuki","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R33-18-20210227","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1439-0507.2001.00706.x","article-title":"Liposomal amphotericinB for prophylaxis of invasive fungal infections in high-risk paediatric patients with chemotherapy-related neutropenia: interim analysis of a prospective study.","volume":"44","author":"Uhlenbrock","year":"2001","journal-title":"Mycoses"},{"key":"R34-18-20210227","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pbc.21239","article-title":"Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation.","volume":"50","author":"Roman","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R35-18-20210227","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.1990.8.2.280","article-title":"Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors.","volume":"8","author":"Wiley","year":"1990","journal-title":"J Clin Oncol"},{"key":"R36-18-20210227","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of CancerInvasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTCMSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R37-18-20210227","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00003495-200767020-00009","article-title":"Voriconazole: a review of its use in the management of invasive fungal infections.","volume":"67","author":"Scott","year":"2007","journal-title":"Drugs"},{"key":"R38-18-20210227","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.pcl.2005.02.009","article-title":"Antifungal agents in children.","volume":"52","author":"Steinbach","year":"2005","journal-title":"Pediatr Clin North Am"},{"key":"R39-18-20210227","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-200203000-00015","article-title":"Voriconazole in treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.","volume":"21","author":"Walsh","year":"2002","journal-title":"Ped Inf Dis"},{"key":"R40-18-20210227","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1200\/JCO.2008.20.1178","article-title":"Approaches to the management of invasive fungal infections in hematologic malignancy and hematopoietic cell transplantation.","volume":"27","author":"Michallet","year":"2009","journal-title":"J Clin Oncol"},{"key":"R41-18-20210227","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1182\/blood-2010-02-268151","article-title":"Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.","volume":"116","author":"Wingard","year":"2010","journal-title":"Blood"},{"key":"R43-18-20210227","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jinf.2007.07.003","article-title":"A double-blind trial on prophylactic voriconazole or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).","volume":"55","author":"Vehreschild","year":"2007","journal-title":"J Infect"},{"key":"R44-18-20210227","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00520-009-0783-3","article-title":"Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.","volume":"19","author":"Mattiuzzi","year":"2011","journal-title":"Support Care Cancer"},{"key":"R46-18-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-3062.2009.00455.x","article-title":"Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.","volume":"12","author":"Martin","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R47-18-20210227","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/bmt.2009.210","article-title":"Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.","volume":"45","author":"Gergis","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R48-18-20210227","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2006.01.018","article-title":"Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.","volume":"55","author":"Siwek","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R50-18-20210227","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":"Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases.","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"key":"R53-18-20210227","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1086\/322653","article-title":"A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients.","volume":"33","author":"Ally","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R54-18-20210227","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM200201243460403","article-title":"Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.","volume":"346","author":"Walsh","year":"2002","journal-title":"N Engl J Med"},{"key":"R55-18-20210227","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM200402263500923","article-title":"Breakthrough zygomycosis after Med voriconazole treatment in recipients of hematopoietic stem cell transplants.","volume":"350","author":"Marty","year":"2004","journal-title":"N Engl J"},{"key":"R56-18-20210227","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/pbc.22451","article-title":"Differences in trough plasma concentrations per oral dosages between children younger and older than 3 years of age.","volume":"54","author":"Shima","year":"2010","journal-title":"Pediatr Blood Can"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e3182331bc7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:29:54Z","timestamp":1786048194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-201112000-00018"}},"subtitle":["A Prospective, Randomized, Clinical Study"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3182331bc7","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}